The Board granted service connection for myelodysplastic syndrome/leukemia, anemia, and hemochromatosis with effective dates of May 7, 2018, June 27, 2019, and June 27, 2019 respectively. The Board also denied service connection for endocarditis, myocarditis, and obstructive sleep apnea.
The deciding factor: The evidence did not support the Veteran's claims for service connection for endocarditis, myocarditis, and obstructive sleep apnea, but supported the earlier effective dates for MDS, anemia, and hemochromatosis based on the date of receipt of the initial claim or the date entitlement arose, whichever is later.
- Claimed conditions
- myelodysplastic syndrome/leukemia (MDS), anemia, hemochromatosis, scar, status-post valve replacement (chest scar), endocarditis, myocarditis, obstructive sleep apnea
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 30%
- Decision date
- February 3, 2025
- Citation
- A25009323
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.